Amdocs Stock Forecast, Price & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DOX stock has increased by 15.2% and is now trading at $70.78.
View which stocks have been most impacted by COVID-19.

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Amdocs stock.
View analyst ratings for Amdocs or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Amdocs a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Amdocs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

1,448 employees have rated Amdocs CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Amdocs' employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, February 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings data on Tuesday, November, 10th. The technology company reported $1.23 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.19 by $0.04. The technology company had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.03 billion. Amdocs had a net margin of 11.94% and a return on equity of 15.57%. The company's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the business posted $1.08 EPS.
View Amdocs' earnings history.

Amdocs declared a quarterly dividend on Tuesday, November 10th. Shareholders of record on Thursday, December 31st will be paid a dividend of $0.327 per share on Friday, January 22nd. This represents a $1.31 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date is Wednesday, December 30th.
View Amdocs' dividend history.

Amdocs pays an annual dividend of $1.31 per share and currently has a dividend yield of 1.85%. Amdocs has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Amdocs is 31.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amdocs will have a dividend payout ratio of 27.52% next year. This indicates that Amdocs will be able to sustain or increase its dividend.
View Amdocs' dividend history.

Amdocs issued an update on its first quarter earnings guidance on Tuesday, November, 10th. The company provided earnings per share guidance of $1.09-1.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.14. The company issued revenue guidance of $1.055-1.095 billion, compared to the consensus revenue estimate of $1.06 billion.

4 analysts have issued 12-month target prices for Amdocs' stock. Their forecasts range from $74.00 to $76.00. On average, they expect Amdocs' share price to reach $75.00 in the next year. This suggests a possible upside of 6.0% from the stock's current price.
View analysts' price targets for Amdocs or view Wall Street analyst' top-rated stocks.

Amdocs saw a decline in short interest in December. As of December 31st, there was short interest totaling 2,170,000 shares, a decline of 15.9% from the December 15th total of 2,580,000 shares. Based on an average daily volume of 665,900 shares, the short-interest ratio is currently 3.3 days. Currently, 1.7% of the company's shares are sold short.
View Amdocs' Short Interest.

Some companies that are related to Amdocs include Accenture (ACN), International Business Machines (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Leidos (LDOS), Gartner (IT), Booz Allen Hamilton (BAH), CACI International (CACI), ManTech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and ServiceSource International (SREV).
View all of DOX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include The Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a variety of institutional and retail investors. Top institutional investors include UNIVEST FINANCIAL Corp (0.09%), Crossmark Global Holdings Inc. (0.08%), State of Alaska Department of Revenue (0.07%), HGK Asset Management Inc. (0.05%), Pineno Levin & Ford Asset Management Inc. (0.03%) and Denali Advisors LLC (0.03%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Denali Advisors LLC, Avantax Advisory Services Inc., State of Alaska Department of Revenue, Crossmark Global Holdings Inc., Bowling Portfolio Management LLC, JustInvest LLC, and Sowell Financial Services LLC.

DOX stock was acquired by a variety of institutional investors in the last quarter, including Pineno Levin & Ford Asset Management Inc., Raymond James Trust N.A., UNIVEST FINANCIAL Corp, HGK Asset Management Inc., Diversified Trust Co, Optimum Investment Advisors, Donald L. Hagan LLC, and Orrstown Financial Services Inc..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $70.78.

Amdocs has a market capitalization of $9.28 billion and generates $4.17 billion in revenue each year. The technology company earns $497.84 million in net income (profit) each year or $4.19 on an earnings per share basis. Amdocs employs 25,875 workers across the globe.

The official website for Amdocs is www.amdocs.com.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]